Blog
RSS FeedPosted by Michael Wonder on 20 Nov 2019
French Authorities approve national reimbursement of Orkambi (lumacaftor/ivacaftor) for eligible people ages two and older with cystic fibrosis
20 November 2019 - Vertex Pharmaceuticals today announced that the French Authorities (Comité économique des produits de santé, or CEPS) ...
Posted by Michael Wonder on 20 Nov 2019
Auckland widow's wish to give away leftover cancer medication illegal under Medicines Act
20 November 2019 - An Auckland widow who spoke out about New Zealand's drug wastage after her husband's death will ...
Posted by Michael Wonder on 20 Nov 2019
Private health premiums tipped to soar as more young people drop cover
19 November 2019 - Health Minister Greg Hunt's effort to slow the increase in the cost of health insurance has ...
Posted by Michael Wonder on 19 Nov 2019
Game changing cancer medicines now within reach for 2,200 Australians
20 November 2019 - Australians living with non-small cell lung cancer and early stage acute lymphoblastic leukaemia will be able to ...
Posted by Michael Wonder on 19 Nov 2019
Lung cancer and leukaemia treatments to be added to PBS
19 November 2019 - “Game changing” drugs for types of lung cancer and leukaemia will be added to the Pharmaceutical Benefits ...
Posted by Michael Wonder on 19 Nov 2019
Epilepsy sufferer says victims of PHARMAC drug switch should be compensated
19 November 2019 - An epilepsy sufferer who urged others to boycott the Government's change in anti-epileptic drug medication is ...
Posted by Michael Wonder on 18 Nov 2019
Ontario and Quebec provide reimbursement for HIV therapies Pifeltro (doravirine) and Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate)
18 November 2019 - For more than 30 years, Merck has been committed to scientific research and discovery in HIV that ...
Posted by Michael Wonder on 18 Nov 2019
The NHS is facing shortages of lifesaving treatments, says internal document
18 November 2019 - Identifies 17 new shortages including drugs for cancer treatment. ...
Posted by Michael Wonder on 18 Nov 2019
Biosimilars make progress in the Canadian market, but stakeholders see more work ahead
18 November 2019 - While much attention over the past few weeks has been on the US biosimilars market, with its ...
Posted by Michael Wonder on 18 Nov 2019
Nancy Brunning's death: calls for PHARMAC reform
18 November 2019 - There are calls for PHARMAC to be reformed after the death of actress Nancy Brunning. ...
Posted by Michael Wonder on 18 Nov 2019
NICE, in confidence: an assessment of redaction to obscure confidential information in single technology appraisals by the National Institute for Health and Care Excellence
17 November 2019 - Health technology assessment aims to provide a transparent framework within which normative judgements can be applied for ...
Posted by Michael Wonder on 18 Nov 2019
Biostatistics: a fundamental discipline at the core of modern health data science
28 October 2019 - The value of our health and medical research investment is at risk unless we foster the discipline ...
Posted by Michael Wonder on 18 Nov 2019
Picturing ELSI+: a visual representation of ethical, legal, and social issues, and patient experiences in health technology assessment in Canada
15 November 2019 - Consideration of ethical, legal, and social issues plus patient values (ELSI+) in health technology assessment is challenging ...
Posted by Michael Wonder on 18 Nov 2019
'This drug saved my life;' cystic fibrosis patient accuses drug company, Canada of stalling on approval
17 November 2019 - A West Island woman living with cystic fibrosis says the prohibitive price of a drug is ...
Posted by Michael Wonder on 16 Nov 2019
Labour will exclude the NHS and medicines from trade deals with the US
17 November 2019 - Donald Trump wants the big US pharmaceutical companies to get its hands on our public services – ...